Categories: News

Love Hemp Group PLC Announces Total Voting Rights

LONDON, UK / ACCESSWIRE / June 1, 2021 / For the purposes of the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules, Love Hemp announces that the Company has 766,230,903 ordinary shares of 1p each in issue, each share carrying the right to one vote. The figure of 766,230,903 should be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority’s Disclosure Guidance and Transparency Rules.

For further information please contact:

Andrew Male
Chairman & Director
+44 (0) 7926 397 675
andrew@worldhighlife.uk
 
AQSE Corporate Adviser
Mark Anwyl/Allie Feuerlein
Peterhouse Capital Limited
+44 (0) 20 7469 0930
ma@peterhousecap.com
af@peterhousecap.com
Financial PR
Tim Blythe
Alice McLaren
Madeleine Gordon-Foxwell
+44 (0) 207 318 3205
lovehemp@blytheweigh.com

Financial Advisor
Rupert Fane
H&P Advisory Limited
+44 (0) 20 7907 8500
rf@hannam.partners

For more information on World High Life please visit www.worldhighlife.uk /. www.lovehempgroup.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

SOURCE: Love Hemp Group PLC

View source version on accesswire.com:
https://www.accesswire.com/649861/Love-Hemp-Group-PLC-Announces-Total-Voting-Rights

Staff

Recent Posts

Clarivate Identifies Eleven Potential Blockbuster and Transformative Drugs in Annual Drugs to Watch Report

Anticipated advancements in obesity, oncology, gene therapy and other areas poised to revolutionize patient care…

2 hours ago

BlackfinBio Ltd announces the acquisition of Parkinson’s IP patent portfolio from OXB

SHEFFIELD, United Kingdom, Jan. 8, 2025 /PRNewswire/ -- BlackfinBio Ltd (BFB) a clinical stage gene therapy…

2 hours ago

Amphastar Pharmaceuticals to Present at the 43rd Annual J.P. Morgan Healthcare Conference

RANCHO CUCAMONGA, CA / ACCESSWIRE / January 8, 2025 / Amphastar Pharmaceuticals, Inc. (NASDAQ:AMPH) announced…

2 hours ago

Hemogenyx Pharmaceuticals PLC Announces Placing to raise £340,000

LONDON, UK / ACCESSWIRE / January 8, 2025 / Hemogenyx Pharmaceuticals plc (LSE:HEMO) is pleased…

5 hours ago

PhenQ Reviews: Legit Fat Burner Supplement or Scam Weight Loss Pills?

PhenQ is a natural weight management system that targets five major areas of metabolic health,…

5 hours ago

Rapid Dose Announces Payment in Shares for Quarterly Interest on Secured Debt

Burlington, Ontario--(Newsfile Corp. - January 7, 2025) - Rapid Dose Therapeutics Corp. (CSE: DOSE) ("RDT"…

14 hours ago